Jevtana Injection - 25 Mg/m2 Dosage, Administered Every 3 Weeks Via Intravenous Infusion, Combines Effectively With Oral Prednisone For Enhanced Cancer Treatment

Due to our vast practical knowledge and in-depth information of this area, we are Distributing, Supplying and Trading an excellent quality collection of Jevtana Injection in Ahmedabad, Gujarat, India to our the most respected clients. Announced that, after a priority review, the fda granted marketing authorization for jevtana cabazitaxel injection, a microtubule inhibitor, in combination with prednisone for the treatment of patients with metastatic hormone-refractory prostate cancer previously treated with a -containing treatment regimen. Jevtana 25 mg/m2 is administered every 3 weeks as a 1-hour intravenous infusion in combination with oral prednisone 10 mg administered daily throughout jevtana treatment.